Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Li, Si-Jie; Hao, Xiaopeng; Bai, Hua; Wang, Jiandong; Fan, Zhimin

doi:10.1097/cm9.0000000000001508

Cited by 7 publications

(8 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After US-VAEB, clinical management regulations depend on pathological results. In a clinical practice guideline for US-VAEB ( 13 ), expert groups recommend that open surgical excision should be performed when the lesion is confirmed to be completely removed and histopathologically diagnosed as breast cancer, atypical ductal hyperplasia, or borderline or malignant phyllodes tumor, while surveillance is appropriate for benign lesions and others. The most common complications after US-VAEB are hematoma and pain.…”

Section: Discussionmentioning

confidence: 99%

“…The lesions in our study all were assigned preoperatively to BI-RADS 3 or 4a, and it was possible that they would have been benign before US-VAEB. BI-RADS 4a category is one of the indications for UE-VAEB ( 13 ). The interpretation of US images and final assessment of BI-RADS category were subjective; therefore, we invited two experienced radiologists to review all the US images of UEBC.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Unexpected breast cancer mimicking benign lesions on ultrasound-guided vacuum-assisted excision biopsy: A retrospective cross-sectional study over a 20-year period

et al. 2023

View full text Add to dashboard Cite

ObjectivesThis study investigated the occurrence rate of unexpected breast cancer (UEBC) mimicking benign lesions [Breast Imaging Reporting and Data System (BI-RADS) category 3 or 4a] using ultrasound-guided vacuum-assisted excision biopsy (US-VAEB), and explored the factors responsible for late diagnosis of T2 stage UEBC.Materials and methodsWe collected clinicopathologic data and preoperative US imaging features within 3 months before US-VAEB of patients who were diagnosed with UEBC from January 2002 to September 2022. The UEBC were divided into T1 and T2 stageUEBC. The US imaging features as well as clinical and pathological information of T1 and T2 stage UEBC were compared to explore the factors responsible for late diagnosis of T2 stage UEBC.ResultsBreast cancer was diagnosed in 91 of 19 306 patients who underwent US-VAEB. We excluded eight patients with breast cancer assigned to BI-RADS 4b category by preoperative US, and two for whom US imaging records were unavailable. Finally, we enrolled 81 patients. The occurrence rate of UEBC after US-VAEB was 0.42%(81/19296). Of the 81 cases of UEBC, 22 were at T2 stage. The ratio of T2 stage UEBC was 27.2%. The differences in risk factor of breast cancer and routine breast US screening between T1 and T2 stage UEBC were significant[96.6% (57/59) vs 81.8% (18/22), 44.1% (26/59) vs 13.6% (3/22), respectively, P<0.05).ConclusionUEBC was rarely detected by US-VAEB. Most cases of T2 stage UEBC were diagnosed late because of the absence of routine US screening and risk factors for breast cancer. Stricter clinical management regulations for breast lesions and performing regular US screening may be helpful to reduce T2 stage UEBC.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Unexpected breast cancer mimicking benign lesions on ultrasound-guided vacuum-assisted excision biopsy: A retrospective cross-sectional study over a 20-year period

et al. 2023

View full text Add to dashboard Cite

show abstract

“…It is thereby seen that CNB has a relatively high pathological underestimation rate for the diagnosis of special pathological types. More details on vacuum-assisted breast biopsy (VABB) usage and diagnostic underestimation can be found in Clinical Practice Guidelines for Ultrasound-guided Vacuum-assisted Breast Biopsy: CSBrS Practice Guidelines 2021 [20] . Clinicians should consider performing a subsequent open surgical resection to make a definitive diagnosis for the abovementioned conditions.…”

Section: Discussionmentioning

confidence: 99%

“…More details on vacuum-assisted breast biopsy (VABB) usage and diagnostic underestimation can be found in Clinical Practice Guidelines for Ultrasound-guided Vacuum-assisted Breast Biopsy: CSBrS Practice Guidelines 2021. [20] Clinicians should consider performing a subsequent open surgical resection to make a definitive diagnosis for the abovementioned conditions. Open surgical biopsy should also be conducted if there is an obvious inconsistency between the puncture biopsy results and the imaging examination.…”

Section: Discussionmentioning

confidence: 99%

Clinical practice guidelines for ultrasound-guided breast lesions and lymph nodes biopsy: Chinese society of breast surgery (CSBrS) practice guidelines 2021

Chen

et al. 2021

Chinese Medical Journal

View full text Add to dashboard Cite

With the maturation and advances of image-guided puncture biopsy technology, the proportion of open breast biopsy has gradually decreased. Ultrasound-guided biopsy is convenient in practice and supports real-time visualization. In order to standardize the practice of ultrasoundguided breast and regional lymph node biopsy, and provide a reference for Chinese breast surgeons, based on the version of Consensus statements and operation guidelines on breast lesions and lymph nodes biopsy guided by ultrasound (2019), [1] the Chinese Society of Breast Surgery (CSBrS) has re-evaluated the quality of the evidence of relevant clinical studies referring to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) handbook and considered domestic medical condition to develop the Clinical Practice Guidelines for Ultrasound-guided Breast Lesions and Lymph Nodes Biopsy: CSBrS Practice Guidelines 2021.

show abstract

“…Therefore, an increasing number of surgical procedures are performed on patients with breast masses that may be breast cancer. With the continuous development of minimally invasive breast technology and focus on the aesthetic needs of patients, minimally invasive resection using the ultrasound (US)-guided Mammotome system has been widely used for the accurate biopsy of suspicious lesions or removal of benign breast masses (2,3), which is particularly efficient for multifocal, tiny and impalpable breast lesions. It has the advantages of being minimally invasive, resulting in tiny scars, having a high accuracy and good performance, and being safe while providing real-time visualization (4,5).…”

Section: Introductionmentioning

confidence: 99%

Value of ultrasound BI‑RADS classification in preoperative evaluation of the ultrasound‑guided Mammotome‑assisted minimally invasive resection of breast masses: A retrospective analysis

Wang

Zhang

et al. 2023

Exp Ther Med

View full text Add to dashboard Cite

The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) classification has been used for the diagnosis of breast masses for several decades and constantly updated, but the terminology used to describe breast ultrasound findings is still evolving and a great amount of large sample data is necessary to verify and improve ultrasound BI-RADS. The objective of the present study was to explore the value of ultrasound Breast Imaging Reporting and Data System (US BI-RADS) classification in the preoperative evaluation of the US-guided Mammotome-assisted minimally invasive resection of breast masses. A total of 1,028 patients with 1,341 breast masses from a single hospital were selected for retrospective analysis. All patients underwent minimally invasive resection using a US-guided Mammotome device, and postoperative pathological examinations were performed for all samples. The preoperative US BI-RADS classification and postoperative pathological examination results were compared and analyzed. A receiver operating characteristic (ROC) curve was used to analyze the preoperative evaluation efficacy of the US BI-RADS classification in US-guided Mammotome-assisted minimally invasive breast mass resection. Among the 1,341 breast masses that underwent resection, 1,307 were benign and 34 were malignant. The specificity, sensitivity, accuracy, positive predictive value and negative predictive value of the US BI-RADS classification in the preoperative diagnosis of malignant breast masses were 83.47, 100.00, 83.89, 13.60 and 100.00%, respectively, and the area under the ROC curve was 0.917. It may be concluded that the US BI-RADS classification has a good preoperative diagnostic performance and can provide an accurate assessment prior to Mammotome-assisted minimally invasive resection. It may help surgeons to make reasonable decisions for subsequent therapy and therefore is worthy of further clinical use.

show abstract

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021

Cited by 7 publications

References 12 publications

Unexpected breast cancer mimicking benign lesions on ultrasound-guided vacuum-assisted excision biopsy: A retrospective cross-sectional study over a 20-year period

Unexpected breast cancer mimicking benign lesions on ultrasound-guided vacuum-assisted excision biopsy: A retrospective cross-sectional study over a 20-year period

Clinical practice guidelines for ultrasound-guided breast lesions and lymph nodes biopsy: Chinese society of breast surgery (CSBrS) practice guidelines 2021

Value of ultrasound BI‑RADS classification in preoperative evaluation of the ultrasound‑guided Mammotome‑assisted minimally invasive resection of breast masses: A retrospective analysis

Contact Info

Product

Resources

About